TENX

1.25010.07%
CT

Christopher T. Giordano

CEO, President & Director

Mr. Christopher T. Giordano, also known as Chris, has been the Chief Executive Officer and Director of Tenax Therapeutics, Inc. since joining in July 14, 2021 and serves as its President since October 29, 2021. He served as Executive Officer of Tenax Therapeutics, Inc. from July 6, 2021 until July 14, 2021. He served as the President of IQVIA Biotech Clinical Solutions at IQVIA Holdings Inc. until April 2021. From March 2018 to July 2021, he served as President of IQVIA Biotech LLC and IQVIA MedTech Inc. (formerly known as Novella Clinical). Mr. Giordano has a deep operational knowledge of clinical trial planning and execution in the CRO industry, supporting sponsors in Europe, Japan and North America. Prior to leading Novella Clinical, Mr. Giordano was global Head of the Cardiovascular, Renal and Metabolic Therapeutic Area at IQVIA, where he also led portfoliowide, end-to end development alliances with several biopharma sponsors. Mr. Giordano was responsible for global delivery of trials across all phases of development and therapeutic areas in these Partnerships. His responsibilities have increased over time from biotech sales, broad business development, trial delivery and joint scientific collaborations with academic research organizations. He served as the Vice President at Quintiles since August 2008, where he oversaw all consulting, regulatory, commercial and clinical development services (including early-phase pharmacology through phase IV registry and safety studies) offered to his clients in the oncology, auto-immune, CNS, cardiovascular and renal disease areas. Prior to that role, from August 2008 to March 2018, he served in roles of increasing responsibility at Quintiles, being appointed Global Vice President of the cardiovascular, renal and metabolic group in February 2016. From January 2001 to July 2008, Mr. Giordano served in various sales and operational roles at PPD, Inc. Mr. Giordano has been involved in the pharmaceutical development industry since 1998. He earned a bachelor’s degree B.A. in English from the University of San Diego, spent as a visiting student at St. Catherine’s College, Oxford and earned an MA in English from the University of North Carolina at Chapel Hill.

公司职务